Expression of angiogenic factors in extrapelvic endometriosis
Extrapelvic and pelvic endometriotic lesions showed differential expression of VEGF and COX-2, with inguinal tumors exhibiting higher immunoreactivity than ovarian tumors.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
The study investigated the expression of the angiogenic factors vascular endothelial growth factor (VEGF) and cyclooxygenase-2 (COX-2) in pelvic versus extrapelvic endometriotic lesions using immunohistochemistry. The authors reported different expression patterns across lesion sites: VEGF immunoreactivity localized mainly to the cytoplasm of adenocytes in inguinal tumors, with no detectable VEGF in ovarian tumors, and COX-2 showed similar findings. A major caveat is that the brief report provides mainly descriptive immunohistochemical results without deeper mechanistic or quantitative analysis. This paper is centrally about endometriosis — specifically the expression of VEGF and COX-2 in extrapelvic endometriotic lesions.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
2,950 characters
· extracted from
oa-doi-fallback
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
Cited by (18)
- Kallistatin in Follicular Fluid of Women with Endometriosis and Its Correlation with IVF Outcome 2021
- Kallistatin in follicular fluid of women with endometriosis and its correlation with IVF outcome 2021
- Basic mechanisms of vascularization in endometriosis and their clinical implications 2018
- Platelets are an unindicted culprit in the development of endometriosis: clinical and experimental evidence 2015
- Polimorfismos genéticos e endometriose: A contribuição dos genes que regulam a função vascular e o remodelamento de tecidos 2012
- Polimorfismos genéticos e endometriose: A contribuição dos genes que regulam a função vascular e o remodelamento de tecidos 2012
- Polimorfismos genéticos e endometriose: A contribuição dos genes que regulam a função vascular e o remodelamento de tecidos 2012
- Association of epidermal growth factor receptor gene polymorphisms with advanced endometriosis in a Korean population 2012
- Slit2 Overexpression Results in Increased Microvessel Density and Lesion Size in Mice With Induced Endometriosis 2012
- Increased immunoreactivity to SLIT/ROBO1 and its correlation with severity of dysmenorrhea in adenomyosis 2010
- Increased Immunoreactivity to SLIT/ROBO1 in Ovarian Endometriomas 2009
- Expression of cyclooxygenase-2 and vascular endothelial growth factor in ovarian endometriotic cysts and their relationship with angiogenesis 2007
- Selective cyclo-oxygenase-2 inhibition induces regression of autologous endometrial grafts by down-regulation of vascular endothelial growth factor-mediated angiogenesis and stimulation of caspase-3-dependent apoptosis 2006
- Endothelial cell survivin is involved in the growth of ovarian endometriotic cysts. 2006
- T homozygote and allele of epidermal growth factor receptor 2073 gene polymorphism are associated with higher susceptibility to endometriosis and leiomyomas 2005
- Immunohistochemical analysis of vascular endothelial growth factor cellular expression in ovarian endometriomata 2004
- Regression of endometrial explants in rats treated with the cyclooxygenase-2 inhibitor rofecoxib 2004
- COX-2 Inhibitors and Their Role in Gynecology 2002
Source provenance
- europepmc
- last seen: 2026-06-18T06:15:08.409253+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:13:19.284922+00:00